Introduction {#S1}
============

The last two decades have seen a revolution in the field of surgical treatment of sporadic primary hyperparathyroidism (pHPT), at least in part due to advances in technology [@R01] [@R02]. The evolution of preoperative imaging studies, the availability of the quick parathyroid hormone assay (qPTHa) and the introduction of cervicoscopy gave great impulse to the application of several variants of minimally-invasive techniques for parathyroidectomy. To date, a minimally-invasive approach to parathyroidectomy emerged as a valid and validated option to treat selected cases of sporadic pHPT, at least in referral centres [@R03], and are assuming an increasingly important role [@R04].

Nonetheless, the diffusion of the minimally-invasive parathyroidectomy has resulted in several controversies regarding the indications for these approaches [@R05]. One of the criticisms regards the role of minimally-invasive parathyroid access in the treatment of a concomitant thyroid pathology [@R06]^-^[@R08], which could represent a relevant limit for the diffusion of these approaches, especially in regions with a high prevalence of goitre. Indeed, in countries with endemic goitre, concomitant thyroid disease is found in 35-78% of patients with pHPT [@R07].

Miccoli [@R09] first described video-assisted parathyroidectomy (VAP), and in 1998 our department adopted the procedure [@R10]. Early after its first description, this technique encountered large, worldwide acceptance [@R10]^-^[@R15] as it is easy to reproduce in different surgical settings. Indeed, it reproduces all the steps of a conventional procedure, with the endoscope representing a tool that allows performing the same operation through a smaller skin incision [@R10]. Thanks to its central access, VAP, in selected cases, allows performing bilateral neck exploration and thyroid resection when necessary through the same central access [@R03] [@R10] [@R16].

The aim of this study was to evaluate the role of VAP in a region with a high prevalence of goitre.

Materials and methods {#S2}
=====================

The medical records of all patients who underwent parathyroidectomy for pHPT and a concomitant thyroid lobectomy (TL) or total thyroidectomy (TT), between May 1998 and June 2012, at our institution were reviewed. Patients who underwent VAP and concomitant video-assisted thyroidectomy (VAT) were included in this study. Demographic, clinical, surgical, pathologic and follow-up data of these patients were evaluated. Statistical analysis was performed using a commercially available software package (SPSS 10.0 for Windows; SPSS Inc., Chicago, Ill). The χ2 test was used for categorical variables, and a t test was used for continuous variables. A p value \< 0.05 was considered statistically significant.

Preoperative work-up {#S2a}
--------------------

Preoperative high-resolution ultrasound (US) and ^99^mTcsestamibi (MIBI) scans were performed in all patients with sporadic pHPT to localize hyperfunctioning glands. All patients had normal renal function (serum creatinine value ranging from 0.7 to 1.2 mg/dl).

Indications {#S2b}
-----------

Ideal candidates for VAP are those with sporadic pHPT in whom a single adenoma is suspected basing on preoperative MIBI-scan and ultrasonography. Parathyroid adenomas larger than 3 cm in their maximum diameter should not be selected for VAP, because a difficult dissection can lead to dangerous capsular rupture. Patients with concomitant nodular goitre requiring surgical removal can be selected for VAP if the inclusion criteria for the video-assisted thyroidectomy (VAT) are respected [@R10] [@R17]. Basing on the surgeons\' experience, in selected cases, patients with previous contralateral neck surgery or intrathymic/retrosternal adenomas can be selected for VAP. In case of suspected multiple gland disease, a video-assisted bilateral exploration can be planned.

Intraoperative-PTH (IOPTH) monitoring {#S2c}
-------------------------------------

All patients underwent IOPTH monitoring. Blood samples were collected peripherally pre-incision (preoperative baseline concentration -- PTH), pre-excision (after dissection and just before clamping the blood supply of the suspected affected gland -- PTH) and at 10 min (PTH-10) and 20 min (PTH-20) after gland excision. A point of care chemiluminescence immunoassay system (Stat-IntraOperative-intact PTH -- Future Diagnostics, Wijchen, The Netherlands) was used for IOPTH measurements and set up in the recovery room. Blood specimens were collected and analyzed following the manufacturer\'s indications [@R18].

Surgical technique {#S2d}
------------------

The surgical technique we use has been previously described elsewhere in detail [@R19]. The patient, under general or loco-regional anaesthesia with cervical block [@R20] [@R21], is positioned supine with the neck in slight extension. A small (1.5 cm) horizontal skin incision is made between the cricoid cartilage and the sternal notch, in the midline. The cervical linea alba is opened as far as possible. The technique is completely gasless. The endoscope (5 mm, 30°) and the dedicated small surgical instruments are introduced through the skin incision without any trocar utilization ([Fig. 1](#F1){ref-type="fig"}). After identifying the inferior laryngeal nerve in the involved side, a targeted exploration is usually carried out to identify the abnormal gland. The magnification (2-3 folds) of the endoscope permits a easy identification of the nerve and the parathyroid glands, if the principles of blunt and bloodless dissection are respected. In case of suspicion of multiglandular disease, bilateral parathyroid exploration can be accomplished. The gland should not be grasped, in order to avoid any capsular rupture. After cutting the pedicle, the adenoma is extracted through the skin incision.

![Video-assisted parathyroidectomy: two small conventional retractors are used to medially retract the thyroid lobe and laterally retract the strap muscles to maintain the operative space. The endoscope (5 mm, 30°) and dedicated small surgical instruments are then introduced through the skin incision without any trocar utilization.](0392-100X-33-388-g001){#F1}

When video-assisted thyroidectomy is required, dissection of the thyroid gland is safely performed under endoscopic vision according to the technique previously described [@R17]^-^[@R19].

Follow-up schedule {#S2e}
------------------

During follow-up, calcium levels combined with intact PTH (iPTH) values were examined at 1, 3 and 6 months after the operation, and the following classification criteria for postsurgical resection outcome at 6 months were used:

group 1: cured patients/operative success: normal or low serum calcium levels for at least 6 months after parathyroidectomy; group 2 -- patients with disease persistence/operative failure: persistent hypercalcaemia and elevated iPTH levels (\> 65 pg/ml; 6.89 pmol/l) within 6 months after surgery.

Results {#S3}
=======

Between May 1998 and June 2012, at our institution 615 patients underwent surgery for primary HPT. Among these, 227 patients (36.9%) underwent concomitant thyroid resection.

Three hundred and eighty four patients with PHPT who fulfilled the inclusion criteria were selected for VAP. Among these, concomitant VAT was carried out in 124 patients (32.3%): 105 females and 19 males, with a mean age of 60.8 ± 10.3 years (range: 38-84). Indications for concomitant thyroid resection were indeterminate nodule within bilateral goitre in 31 cases and multinodular goitre (MNG) with compressive symptoms in the remaining 93 cases. The mean diameter of the dominant nodule of the 93 cases of MNG was 20.3 ± 9.8 mm (range: 2-46 mm). Video-assisted TL was performed in 26 cases and video-assisted TT in 98 cases. No conversion to conventional surgery was necessary. The mean operative time of all procedures was 66.6 ± 43.6 min (range: 30-175). In particular, the mean operative time of VAP associated to video-assisted TL was 63.19 ± 38.1 min (range: 30- 170); the parathyroid lesion was ipsilateral to the side of the thyroid lobectomy in 19 cases and contralateral in the remaining 7 cases. The mean operating time for VAP associated with video-assisted TT was 68.27 ± 32.5 min (range: 40-175). Transient hypocalcaemia was observed in 42 cases (32.8%), transient recurrent lesion in one case (0.8%). No other complications occurred. Mean postoperative hospital stay was 3.4 ± 1.7 days (range: 3-7). Most patients (93%) considered the cosmetic result as excellent as evaluated by a verbal response scale ([Fig. 2a](#F2a){ref-type="fig"}-[b](#F2b){ref-type="fig"}).

![Cosmetic result of a VAP at two weeks after surgery.](0392-100X-33-388-g002a){#F2a}

![Cosmetic result of a VAP at six months after surgery.](0392-100X-33-388-g002b){#F2b}

Final histology showed parathyroid adenoma in all but two cases of parathyroid carcinomas.

In particular, in these latter two cases, no signs and/or suspicions of malignancy were present on the basis of pre-operative evaluation; in both cases simultaneous videoassisted total thyroidectomy for a concomitant bilateral thyroid disease was performed.

Final histology of thyroid specimens revealed benign goitre in 119 cases and papillary thyroid carcinoma in 5 cases. The preoperative cytological examination of the five cases of papillary thyroid carcinoma was consistent with indeterminate nodules. After a mean follow-up of 33.2 ± 20.0 months (range: 3-110), no persistent recurrent parathyroid or thyroid disease was observed.

Discussion {#S4}
==========

The results of VAP in terms of cure and complication rates are similar and rival those of conventional surgery. This has been extensively demonstrated in the international literature [@R03] [@R04] [@R16], and it is also confirmed in our personal experience [@R10] [@R18] [@R19].

Some criticisms about the technical aspects for MIVAP have concerned the operating time. However, it has been demonstrated in large retrospective series [@R10] [@R14] as well as in small comparative, randomized trials [@R03] [@R22] that the operating time does not represent a limit. A prospective, randomized, small comparative study (level II evidence) showed that the operating time for MIVAP was significantly shorter than conventional bilateral exploration and similar to open minimally-invasive parathyroidectomy [@R22].

In addition, in our overall experience with exclusive VAP and IOPTH the mean operating time was 42.6 ± 18.1 min (range: 15-95).

Besides its reproducibility, VAP also seems to offer significant advantages over conventional surgery in terms of patient satisfaction with the cosmetic result and postoperative recovery [@R03]. Moreover, it has been demonstrated that in selected cases of pHPT, VAP is curative and safe considering short- and medium-term outcome and complications [@R10]^-^[@R14] [@R22] [@R23].

The association between benign and malignant thyroid disease with pHPT has been previously described [@R05]^-^[@R08]. Indeed, the presence of concomitant thyroid disease has been reported in 15%-70% of patients with pHPT [@R24] [@R25]. In a surgical series of 51 patients with pHPT, Kösem described 43 cases (84.3%) of coexistent thyroid diseases. Among these, 9 patients (17.6%) had papillary thyroid cancer [@R26].

The association between pHPT and goitre seems to be more much relevant in areas with iodine deficiency. It has been reported that in an endemic goitre region, 67 of 137 patients with PHPT (49%) had concomitant thyroid disease [@R07].

In a large retrospective analysis involving a population living in a geographical area with an average-mild iodine deficiency, such as the mixed Italian regions, a total of 124 of 241 patients (51.5%) with pHPT showed concomitant thyroid disorders [@R27].

It has been pointed out that a head and neck endocrine surgeon needs to be aware of the possible coexistence of thyroid and parathyroid disease so that, when encountered, they can be safely and effectively managed in a single procedure [@R24] [@R25]. However, some authors have argued that concomitant thyroid disease requiring surgical management represents an exclusion criteria for minimally-invasive parathyroidectomy [@R05] [@R06]. Perrier [@R05] reported that 17% of patients referred to parathyroidectomy were considered ineligible for localized parathyroid surgery because of a coexisting thyroid pathology. However, a relevant advantage of central access is the possibility to perform thyroid resection, even bilateral, when necessary. This introduces an important difference when compared to other minimally-invasive techniques, as conversion to a conventional approach is usually required when bilateral thyroid resection is needed [@R28]. Because of the high prevalence of multinodular goitre in some countries, the central approach of VAP can allow experienced surgeons to increase the number of patients eligible for a video-assisted procedure. Indeed, in our experience in a region of high prevalence of goitre in Italy, the video-assisted approach was successful accomplished in the treatment of both parathyroid and thyroid disease during the same procedure in a significant percentage of patients (32.3%).

Moreover, concomitant thyroid diseases with pHPT may result in more difficult preoperative localization of the pathological parathyroid gland. Indeed, in these cases, one of the main problems is the accuracy of preoperative imaging studies. It has been reported that the coexistence of pHPT and thyroid disease may reduce the sensitivity of sestaMIBI from 81% to 75%, and of US from 73% to 55% [@R29]. However, the combined use of sestaMIBI and US seems to be more effective in patients with pHPT for localization of an enlarged parathyroid gland even in the case of concomitant thyroid disease [@R29]. This would make it possible to perform a focused parathyroidectomy in the most of patients suffering from pHPT even in an endemic goitre region [@R07].

Moreover, it might be stressed that even if preoperatively, well-documented single adenoma is a prerequisite for any type of focused parathyroidectomy [@R01] [@R30], the concept that preoperative localization studies are mandatory when performing a minimally-invasive approach remains valid only for procedures that imply a unilateral approach. Among these, the lateral approach (VAP-LA) described by Henry which is the most diffuse, has been shown to be effective and safe, with a minimal complication rate [@R31]. Nonetheless, due to its unilateral approach, the rate of contraindications for VAP-LA appears fairly high (43%) compared to that of large series of VAP [@R23]. This may depend on the need of stricter eligibility criteria, due to the unilaterality of the approach, which implies the strong demonstration of a single enlarged parathyroid gland on preoperative imaging studies and excludes bilateral thyroid disease. The main technical limitation of the technique is, indeed, that a unilateral approach prevents the possibility to accomplish bilateral exploration when necessary without conversion to an open conventional procedure [@R28] [@R30] [@R31].

On the other hand, a relevant merit of VAP is the possibility of performing bilateral neck exploration when necessary through the same central access. This characteristic in part explains the lack of conversion in the present series and the very low conversion rate generally reported for VAP [@R10] [@R16]. Moreover, the possibility of performing a bilateral neck exploration produces two main effects on the restrictive inclusion criteria. First, at least from a theoretical point of view, VAP can be performed if IOPTH monitoring is not available or in the case of inadequate preoperative localization, given the ability to explore all parathyroid sites through this approach [@R10] [@R23] [@R32].

In our experience in an endemic goitre area, 62.4% of patients with PHPT were eligible for VAP. The possibilities given by central access allowed us to treat a significant percentage of patients with concomitant thyroid disease who fulfilled the indication criteria of VAT. No conversion to conventional surgery was necessary and no definitive complications occurred. After a mean follow-up of 33.2 months, no persistent or recurrent parathyroid or thyroid diseases was observed.

Conclusions {#S5}
===========

When selection criteria are followed, the treatment of synchronous thyroid and parathyroid disorders can be accomplished using a minimally-invasive procedure. In our experience, a video-assisted approach is feasible, effective and safe for the treatment of synchronous thyroid and parathyroid disorders, at least considering short-term follow-up.
